CC BY 4.0 · The Arab Journal of Interventional Radiology 2023; 07(01): 026-030
DOI: 10.1055/s-0043-1763496
Original Article

Bronchial Artery Embolization in Management of Hemoptysis in a Developing Country: An Initial Experience

Puneet Garg
1   Department of Radiodiagnosis, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
,
1   Department of Radiodiagnosis, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
,
Krishna Bhardwaj
1   Department of Radiodiagnosis, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
,
2   Department of Pulmonary, Critical Care and Sleep Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
,
Rajat Khurana
1   Department of Radiodiagnosis, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
,
1   Department of Radiodiagnosis, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
› Author Affiliations
Funding None.

Abstract

Objectives This article evaluates the immediate success, recurrence rate, complications, and the culprit vessel of bronchial artery embolization (BAE) in patients presenting with hemoptysis.

Materials and Methods All patients who underwent BAE from July 1, 2018 to August 31, 2021 were included. BAE was done for moderate to severe hemoptysis or for mild hemoptysis which was recurrent and not controlled by medical management. Patients referred for surgical intervention and hemoptysis controlled on medical management were excluded.

Results One hundred and thirty patients underwent BAE in the study period. Mean age was 41.5 years and majority (73.1%) was male. Forty-three (33.1%) patients had mild, 46 (35.4%) had moderate, and 41 (31.5%) with the duration of symptoms ranging from 3 days to 25 years. Most common culprit vessel was posterior intercostal artery closely followed by the intercostobronchial artery. Hypervascularity was the most common angiographic abnormality encountered. On an average, 2.75 vessels were embolized per BAE with a wide range of 1 to 8 vessels. Hemoptysis control was seen in 96.1% patients immediately, 90.7 % at 1 month, 82.3 % at 3 months, and 66.9 % at 6 months. Overall recurrence was seen in 43 patients (33.1%). Chest pain was the most common minor side effect occurring in 77.1% cases.

Conclusion BAE is a safe and effective procedure that can be performed routinely in patients presenting with moderate to massive hemoptysis or with mild hemoptysis refractory to medical management.

Ethical Approval Statement

Ethical approval was taken from the institute's ethics committee.


Consent for Publication

Written informed consent was taken from the patients.


Data Availability Statement

Written informed consent was taken from all study participants to share their clinical data.


Authors' Contribution

P.G., A.K., P.I. involved in conceptualization, literature search, writing the original draft of manuscript, literature search, planning, conduct, and editing. P.G., A.K., K.B., A.M., P.I., R.K. involved in review and editing. All the authors have agreed with the submitted manuscript.




Publication History

Article published online:
03 March 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Ibrahim WH. Massive haemoptysis: the definition should be revised. Eur Respir J 2008; 32 (04) 1131-1132
  • 2 Jean-Baptiste E. Clinical assessment and management of massive hemoptysis. Crit Care Med 2000; 28 (05) 1642-1647
  • 3 Yoon W, Kim JK, Kim YH, Chung TW, Kang HK. Bronchial and nonbronchial systemic artery embolization for life-threatening hemoptysis: a comprehensive review. Radiographics 2002; 22 (06) 1395-1409
  • 4 Hirshberg B, Biran I, Glazer M, Kramer MR. Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital. Chest 1997; 112 (02) 440-444
  • 5 Tanomkiat W, Tanisaro K. Radiographic relationship of the origin of the bronchial arteries to the left main bronchus. J Thorac Imaging 2003; 18 (01) 27-33
  • 6 Cauldwell EW, Siekert RG. et al. The bronchial arteries; an anatomic study of 150 human cadavers. Surg Gynecol Obstet 1948; 86 (04) 395-412
  • 7 Hartmann IJC, Remy-Jardin M, Menchini L, Teisseire A, Khalil C, Remy J. Ectopic origin of bronchial arteries: assessment with multidetector helical CT angiography. Eur Radiol 2007; 17 (08) 1943-1953
  • 8 Panda A, Bhalla AS, Goyal A. Bronchial artery embolization in hemoptysis: a systematic review. Diagn Interv Radiol 2017; 23 (04) 307-317
  • 9 Angle JF, Siddiqi NH, Wallace MJ. Quality improvement guidelines for percutaneous transcatheter embolization: Society of Interventional Radiology Standards of Practice Committee. J Vasc Interv Radiol 2010; 21 (10) 1479-1486
  • 10 Remy J, Voisin C, Ribet M. et al. Treatment, by embolization, of severe or repeated hemoptysis associated with systemic hypervascularization [in French]. Nouv Presse Med 1973; 2 (31) 2060
  • 11 Chan VL, So LKY, Lam JYM. et al. Major haemoptysis in Hong Kong: aetiologies, angiographic findings and outcomes of bronchial artery embolisation. Int J Tuberc Lung Dis 2009; 13 (09) 1167-1173
  • 12 Mal H, Rullon I, Mellot F. et al. Immediate and long-term results of bronchial artery embolization for life-threatening hemoptysis. Chest 1999; 115 (04) 996-1001
  • 13 Poyanli A, Acunas B, Rozanes I. et al. Endovascular therapy in the management of moderate and massive haemoptysis. Br J Radiol 2007; 80 (953) 331-336
  • 14 Antonelli M, Midulla F, Tancredi G. et al. Bronchial artery embolization for the management of nonmassive hemoptysis in cystic fibrosis. Chest 2002; 121 (03) 796-801
  • 15 Swanson KL, Johnson CM, Prakash UBS, McKusick MA, Andrews JC, Stanson AW. Bronchial artery embolization : experience with 54 patients. Chest 2002; 121 (03) 789-795
  • 16 Shao H, Wu J, Wu Q. et al. Bronchial artery embolization for hemoptysis: a retrospective observational study of 344 patients. Chin Med J (Engl) 2015; 128 (01) 58-62
  • 17 Uflacker R, Kaemmerer A, Picon PD. et al. Bronchial artery embolization in the management of hemoptysis: technical aspects and long-term results. Radiology 1985; 157 (03) 637-644
  • 18 Bhalla A, Kandasamy D, Veedu P, Mohan A, Gamanagatti S. A retrospective analysis of 334 cases of hemoptysis treated by bronchial artery embolization. Oman Med J 2015; 30 (02) 119-128
  • 19 Rabkin JE, Astafjev VI, Gothman LN, Grigorjev YG. Transcatheter embolization in the management of pulmonary hemorrhage. Radiology 1987; 163 (02) 361-365
  • 20 Lee S, Chan JWM, Chan SCH. et al. Bronchial artery embolisation can be equally safe and effective in the management of chronic recurrent haemoptysis. Hong Kong Med J 2008; 14 (01) 14-20
  • 21 Singhal S, Banode P. Bronchial artery embolization in patients presenting with massive hemoptysis: initial experience from a rural tertiary centre of central India. Int Sch Res Not 2011; 2011: 1-5
  • 22 Agmy GM, Wafy SM, Mohamed SA. et al. Bronchial and nonbronchial systemic artery embolization in management of hemoptysis: experience with 348 patients. Int Sch Res Not 2013; 26: e263259
  • 23 Mishra A, Mathur A, Pathak K, Katoch CD, Khera A. Bronchial artery embolization in treatment of hemoptysis: treatment efficacy and complications at a tertiary care chest centre. Med J Armed Forces India 2018; 74 (04) 352-357
  • 24 Hwang JH, Kim JH, Park S, Lee KH, Park SH. Feasibility and outcomes of bronchial artery embolization in patients with non-massive hemoptysis. Respir Res 2021; 22 (01) 221
  • 25 Dorji K, Hongsakul K, Jutidamrongphan W, Oofuvong M, Geater S. Bronchial artery embolization in life-threatening hemoptysis: outcome and predictive factors. J Belg Soc Radiol 2021; 105 (01) 5